Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells.

NCT01868490 is registered in ClinicalTrials.gov with Siriraj Hospital as lead sponsor.

NCT NCT01868490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01868490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells.
Lead sponsor
Siriraj Hospital
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
April 17, 2009
Completion date
May 30, 2028
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, neuroblastoma